Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
Introduction: PanNETs are the second most common type of tumour of the pancreas. Most patients have metastatic disease at diagnosis with median survival ranges from 2 to 5 years. Somatostatin analogs (SSAs) control symptoms and reduce tumour growth in panNET. In the panNET subgroup of the CLARINET study, lanreotide autogel 120 mg reduced the relative risk of progression or death by more than 40% compared with placebo at week 96.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author:
Authors: Teulé A, Alonso T, González E, De La Cruz G, Houchard A,
Keywords: NET, lanreotide, pancreas, study,
Introduction: NET pts have high rates of mortality and morbidity, as wells as decreased health-related quality of life (HRQoL) due to CS. Though there is little research on the economic impact of CS, recent studies show that some symptoms, i.e. diarrhoea, are associated with higher healthcare expenditure and use of resources.
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author:
Authors: Custodio A, Carmona-Bayonas A, Villabona C, Perez M, de La Cruz G,
Keywords: neuroendocrine tumors, carcinoid syndrome, use of resources, costs,
Introduction: Neuroendocrine tumors (NET) have widely varying characteristics, localizations, and treatments. Consequently, a multidisciplinary approach to diagnosis and treatment is necessary. Given the heterogeneous management of this disease, we conducted an ecological survey to assess usual clinical practice in Spain.
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author:
Authors: Guardeño R, García P, Ginés R, De la Cruz G,
Keywords: gastrointestinal, neuroendocrine, pancreatic tumors, survey, Spain,